JP2023539614A5 - - Google Patents
Info
- Publication number
- JP2023539614A5 JP2023539614A5 JP2023513654A JP2023513654A JP2023539614A5 JP 2023539614 A5 JP2023539614 A5 JP 2023539614A5 JP 2023513654 A JP2023513654 A JP 2023513654A JP 2023513654 A JP2023513654 A JP 2023513654A JP 2023539614 A5 JP2023539614 A5 JP 2023539614A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013721.2 | 2020-09-01 | ||
| GBGB2013721.2A GB202013721D0 (en) | 2020-09-01 | 2020-09-01 | New compounds |
| PCT/GB2021/052254 WO2022049372A1 (en) | 2020-09-01 | 2021-09-01 | Novel compounds for use in the treatment of diseases associated with angiotensin ii |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539614A JP2023539614A (ja) | 2023-09-15 |
| JP2023539614A5 true JP2023539614A5 (https=) | 2024-09-05 |
| JPWO2022049372A5 JPWO2022049372A5 (https=) | 2024-09-05 |
Family
ID=72749608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513654A Pending JP2023539614A (ja) | 2020-09-01 | 2021-09-01 | アンジオテンシンｉｉに関連する疾患の治療に使用するための新規化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230348444A1 (https=) |
| EP (1) | EP4208460A1 (https=) |
| JP (1) | JP2023539614A (https=) |
| KR (1) | KR20230058467A (https=) |
| CN (1) | CN116568682A (https=) |
| AU (1) | AU2021337193A1 (https=) |
| CA (1) | CA3189240A1 (https=) |
| CL (1) | CL2023000580A1 (https=) |
| CO (1) | CO2023002347A2 (https=) |
| GB (1) | GB202013721D0 (https=) |
| IL (1) | IL300582A (https=) |
| MX (1) | MX2023002522A (https=) |
| WO (1) | WO2022049372A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4313953A1 (en) * | 2021-03-23 | 2024-02-07 | Vicore Pharma AB | Selective angiotensin ii receptor ligands |
| GB202104033D0 (en) * | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| GB202104038D0 (en) * | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| WO2024149712A1 (en) * | 2023-01-09 | 2024-07-18 | Vicore Pharma Ab | Selective angiotensin ii compounds |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5198438A (en) * | 1991-05-07 | 1993-03-30 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5312820A (en) | 1992-07-17 | 1994-05-17 | Merck & Co., Inc. | Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A & Science Invest Ab | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| YU78601A (sh) * | 1999-05-05 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže |
| KR100938817B1 (ko) * | 2001-05-31 | 2010-01-26 | 바이코어 파마 아베 | 안지오텐신 ⅱ 작용제로 유용한 삼중고리 화합물 |
| CA2449150C (en) | 2001-05-31 | 2011-07-12 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
| WO2004046141A1 (en) | 2002-11-21 | 2004-06-03 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| AU2006235698B2 (en) * | 2005-04-12 | 2012-03-29 | Vicore Pharma Ab | New tricyclic angiotensin II agonists |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| BR112017012337A2 (pt) | 2014-12-12 | 2018-02-27 | Vicore Pharma Ab | Método para tratamento de doença falciforme, agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró- fármaco do mesmo, uso de um agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró-fármaco do mesmo, formulação farmacêutica, e, produto de combinação. |
| WO2016107879A2 (en) | 2014-12-30 | 2016-07-07 | Vicore Pharma Ab | New use of angiotensin ii receptor agonists |
| CN107405406A (zh) | 2015-03-02 | 2017-11-28 | 维科尔药物公司 | 用于治疗肺纤维化的血管紧张素ii受体激动剂 |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201710906D0 (en) | 2017-07-06 | 2017-08-23 | Vicore Pharma Ab | Compounds and methods for treating peripheral neuropathy |
| GB201913603D0 (en) * | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
-
2020
- 2020-09-01 GB GBGB2013721.2A patent/GB202013721D0/en not_active Ceased
-
2021
- 2021-09-01 EP EP21773137.1A patent/EP4208460A1/en active Pending
- 2021-09-01 WO PCT/GB2021/052254 patent/WO2022049372A1/en not_active Ceased
- 2021-09-01 KR KR1020237010733A patent/KR20230058467A/ko not_active Withdrawn
- 2021-09-01 AU AU2021337193A patent/AU2021337193A1/en not_active Abandoned
- 2021-09-01 JP JP2023513654A patent/JP2023539614A/ja active Pending
- 2021-09-01 CA CA3189240A patent/CA3189240A1/en active Pending
- 2021-09-01 US US18/023,164 patent/US20230348444A1/en active Pending
- 2021-09-01 IL IL300582A patent/IL300582A/en unknown
- 2021-09-01 CN CN202180053934.XA patent/CN116568682A/zh active Pending
- 2021-09-01 MX MX2023002522A patent/MX2023002522A/es unknown
-
2023
- 2023-02-28 CL CL2023000580A patent/CL2023000580A1/es unknown
- 2023-02-28 CO CONC2023/0002347A patent/CO2023002347A2/es unknown